Cerebrospinal fluid isoprostanes are not related to inflammatory activity in relapsing–remitting multiple sclerosis
- 1 September 2004
- journal article
- research article
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 224 (1-2) , 23-27
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Inflammation in multiple sclerosis: the good, the bad, and the complexThe Lancet Neurology, 2002
- The role of nitric oxide in multiple sclerosisThe Lancet Neurology, 2002
- Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosisAnnals of Neurology, 2001
- Elevation of neuron-specific enolase in serum and cerebrospinal fluid of early stage Creutzfeldt-Jakob diseaseActa Neurologica Scandinavica, 2000
- Cerebrospinal fluid isoprostane shows oxidative stress in patients with multiple sclerosisNeurology, 1999
- Demyelination: The Role of Reactive Oxygen and Nitrogen SpeciesBrain Pathology, 1999
- Nitrite and nitrate levels in cerebrospinal fluid of normal subjectsJournal of Neural Transmission, 1998
- Spectrophotometric detection of nitrogen oxides using azo dyesNeuroprotocols, 1992
- Cerebrospinal fluid eicosanoid levelsNeurology, 1991
- Prostaglandin levels in cerebrospinal fluid from multiple sclerosis patients in remission and relapseJournal of Neuroimmunology, 1984